These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 21156284)
41. Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML. Kaushik S; Liu F; Veazey KJ; Gao G; Das P; Neves LF; Lin K; Zhong Y; Lu Y; Giuliani V; Bedford MT; Nimer SD; Santos MA Leukemia; 2018 Feb; 32(2):499-509. PubMed ID: 28663579 [TBL] [Abstract][Full Text] [Related]
42. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. So CW; Karsunky H; Wong P; Weissman IL; Cleary ML Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702 [TBL] [Abstract][Full Text] [Related]
43. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991 [TBL] [Abstract][Full Text] [Related]
44. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229 [TBL] [Abstract][Full Text] [Related]
45. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682 [TBL] [Abstract][Full Text] [Related]
46. Initiation of MLL-rearranged AML is dependent on C/EBPα. Ohlsson E; Hasemann MS; Willer A; Lauridsen FK; Rapin N; Jendholm J; Porse BT J Exp Med; 2014 Jan; 211(1):5-13. PubMed ID: 24367003 [TBL] [Abstract][Full Text] [Related]
47. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795 [TBL] [Abstract][Full Text] [Related]
48. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation. Chen Y; Ernst P Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857 [TBL] [Abstract][Full Text] [Related]
49. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693 [TBL] [Abstract][Full Text] [Related]
50. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia. Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424 [TBL] [Abstract][Full Text] [Related]
51. Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells? Somervaille TC; Cleary ML Int J Hematol; 2010 Jun; 91(5):735-41. PubMed ID: 20454944 [TBL] [Abstract][Full Text] [Related]
52. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
53. The MLL/Setd1b methyltransferase is required for the Spemann's organizer gene activation in Xenopus. Lin H; Min Z; Tao Q Mech Dev; 2016 Nov; 142():1-9. PubMed ID: 27519569 [TBL] [Abstract][Full Text] [Related]
54. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503 [TBL] [Abstract][Full Text] [Related]
55. Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells. Yuan J; Takeuchi M; Negishi M; Oguro H; Ichikawa H; Iwama A Leukemia; 2011 Aug; 25(8):1335-43. PubMed ID: 21527932 [TBL] [Abstract][Full Text] [Related]